Company record
DSM FIRMENICH AG
- Kaiseraugst
- CH1216478797
- Listed issuer
Size source: afm-register
Subsidiaries · 1
Signals
109 on record
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.42%, down from 4.44%. Voting rights 4.98%, down from 5%. Voting rights threshold down through: 5%.
AFM stakesRelevance87
Medium · 93% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication AU2025296295A1 by DSM IP ASSETS B.V.: METHOD, SYSTEM AND COMPUTER SOFTWARE TO AUTOMATICALLY FORMULATE AN ANIMAL FEED ADDITIVE COMPOSITION.
EPO patentsRelevance21
Watch · 80% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.44%, up from 4.39%. Voting rights 5%, up from 4.96%. Voting rights threshold crossed: 5%.
AFM stakesRelevance87
Medium · 93% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026234290A1 by DSM IP ASSETS B.V.: NON-THERAPEUTIC, NON-FOOD PREPARATIONS COMPRISING DIHYDROMYRICETIN.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260354962A1 by DSM IP Assets B.V.: GRAFT.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260354416A1 by DSM IP Assets B.V.: A COMPOSITION FOR MODULATING GROWTH OF MICROORGANISMS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026234249A1 by DSM IP ASSETS B.V.: GELLED COMPOSITION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260356864A1 by DSM IP Assets B.V.: NEW INTERMEDIATE FOR ß-CAROTENE SYNTHESIS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026234291A1 by DSM IP ASSETS B.V.: USE OF THIOL-CONTAINING COMPOUND FOR THE STABILIZATION OF A FLAVANONOL.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026234250A1 by DSM IP ASSETS B.V.: THIN FILM COMPOSITION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026229559A1 by DSM IP ASSETS B.V.: SENOLYTIC AGENT AND USE THEREOF.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026229530A1 by DSM IP ASSETS B.V.: METHODS AND SYSTEMS FOR PROVIDING PREDICTED BIOLOGICAL ACTIVITY AND FOR PROVIDING A BIOLOGICALLY ACTIVE PEPTIDE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026229582A1 by DSM IP ASSETS B.V.: SENOLYTIC AGENT AND USE THEREOF.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026229633A1 by DSM IP ASSETS B.V.: PROCESS FOR THE PREPARATION OF BENZOTRIAZOLE DERIVATIVES AND COMPOSITION COMPRISING SUCH BENZOTRIAZOLE DERIVATIVES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260345696A1 by DSM IP Assets B.V.: COMBINATIONS COMPRISING VITAMIN C AND BIFIDOBACTERIUM ANIMALIS SSP. LACTIS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260344723A1 by DSM IP Assets B.V.: PREPARATION AND COMPOSITIONS COMPRISING SACCHARIDES AND AMINO ACIDS, AND USE THEREOF.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4833324A2 by DSM IP Assets B.V.: CELLS AND METHODS FOR THE PRODUCTION OF GLYCOSYLATED COMPOUNDS.
EPO patentsRelevance21
Watch · 80% confidence
- EuronextGuidance / profit warning
DSM FIRMENICH AG: dsm-firmenich reports Q3 2026 trading update. Topic: Commercial results. Industry: 45102020 Food Products.
EuronextRelevance52
Medium · 80% confidence
- AFM shortsNet short position
Ilex Capital Partners (UK) LLP net short position is 2.16% of DSM-Firmenich AG (CH1216478797), down 0.04% from 2.2%.
AFM shortsRelevance68
High · 95% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.39%, up from 4.38%. Voting rights 4.96%, up from 4.95%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4827747A1 by DSM IP Assets B.V.: SUNSCREEN COMPOSITIONS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4827740A1 by DSM IP Assets B.V.: SUNSCREEN COMPOSITIONS.
EPO patentsRelevance21
Watch · 80% confidence
- AFM shortsNet short position
Capital Fund Management S.A. net short position is 0.49% of DSM-Firmenich AG (CH1216478797), down 0.08% from 0.57%.
AFM shortsRelevance68
Medium · 95% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260325423A1 by DSM IP Assets B.V.: TOPICAL COMPOSITION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication AU2025256782A1 by DSM IP ASSETS B.V.: NUTRITIONAL COMPOSITION COMPRISING BIFIDOBACTERIUM LONGUM SSP. INFANTIS R0033 AND HUMAN MILK OLIGOSACCHARIDES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026219923A1 by DSM IP ASSETS B.V.: USE OF A COMBINATION OF 3-NITROOXYPROPANOL AND/OR DERIVATIVES THEREOF AND DIBROMOMETHANE FOR REDUCING THE FORMATION OF METHANE EMANATING FROM THE DIGESTIVE ACTIVITIES OF RUMINANTS AND ANIMAL FEED PREMIX.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026219914A1 by DSM IP ASSETS B.V.: NOVEL USE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4824030A1 by DSM IP Assets B.V.: MANUFACTURE OF ALLYLIC ALCOHOLS CARRYING A TERMINAL CARBOXYL GROUP VIA ETHYNYLATION AND LINDLAR HYDROGENATION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4823348A1 by DSM IP Assets B.V.: AQUACULTURE FEED.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4824029A1 by DSM IP Assets B.V.: MANUFACTURE OF ALPHA, BETA, GAMMA, DELTA OR BETA, GAMMA, DELTA DI-UNSATURATED KETONES CARRYING A TERMINAL CARBOXYL GROUP.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4823349A1 by DSM IP Assets B.V.: NOVEL USE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4823350A1 by DSM IP Assets B.V.: NOVEL USE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4823351A1 by DSM IP Assets B.V.: NOVEL USE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4823352A1 by DSM IP Assets B.V.: USE OF 3-NITROOXYPROPANOL AND METRONIDAZOL FOR REDUCING THE FORMATION OF METHANE EMANATING FROM THE DIGESTIVE ACTIVITIES OF RUMINANTS.
EPO patentsRelevance21
Watch · 80% confidence
- AFM insidersInsider transaction
Ridinger R. (member Board of Directors) bought 1,624 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Leysen T. (chairman Board of Directors) sold 3,256 gewoon aandeel at 108.6 EUR (CH1216478797); bought 11,369 gewoon aandeel at 109.6 EUR (CH1216478797); sold 11,369 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
High · 94% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.49% of DSM-Firmenich AG (CH1216478797), down 0.09% from 0.58%.
AFM shortsRelevance68
Medium · 95% confidence
- EuronextExecutive change
DSM FIRMENICH AG: dsm-firmenich shareholders elect Richard Ridinger as Chairman of the Board of Directors. Topic: Journal / appointments. Industry: 45102020 Food Products.
EuronextRelevance41
Medium · 80% confidence
- AFM shortsNet short position
Ilex Capital Partners (UK) LLP net short position is 2.2% of DSM-Firmenich AG (CH1216478797), up 0.1% from 2.1%.
AFM shortsRelevance68
High · 95% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260317260A1 by DSM IP Assets B.V.: PROCESS FOR THE PREPARATION OF 1,1,4,4-TETRAALKYLOXY-2-BUTENE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260317732A1 by DSM IP Assets B.V.: NEW FUCOSYLTRANSFERASES FOR IN VIVO SYNTHESIS OF COMPLEX FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES MIXTURES COMPRISING LNDFH-III.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260315348A1 by DSM IP Assets B.V.: SUNSCREEN COMPOSITION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260315526A1 by DSM IP Assets B.V.: A NOVEL FEED COMPOSITION.
EPO patentsRelevance21
Watch · 80% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.38%, down from 4.4%. Voting rights 4.95%, down from 4.97%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026215211A2 by DSM IP ASSETS B.V.: PRODUCTION OF A DAIRY PRODUCT.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260317791A1 by DSM IP Assets B.V.: METHOD OF REDUCING EMULSION FORMATION DURING FERMENTATION PROCESS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026215276A1 by DSM IP ASSETS B.V.: COMPOSITIONS COMPRISING EXOSOMES.
EPO patentsRelevance21
Watch · 80% confidence
- AFM shortsNet short position
Capital Fund Management S.A. net short position is 0.57% of DSM-Firmenich AG (CH1216478797), down 0.03% from 0.6%.
AFM shortsRelevance68
Medium · 95% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026209710A1 by DSM IP ASSETS B.V.: CLAY FOR IMPROVING VEAL CALF PRODUCTION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260306519A1 by DSM IP ASSETS B.V.: REDUCING NECROTIC ENTERITIS EFFECT IN A BIRD USING AN OLIGOSACCHARIDE PREPARATION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260306708A1 by DSM IP Assets B.V.: SYNTHETIC BIOPOLYMER SOLUTIONS WITH INCREASED LOWER CRITICAL SOLUTION TEMPERATURES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026209825A1 by DSM IP ASSETS B.V.: IMPROVED CBD FORMULATIONS.
EPO patentsRelevance21
Watch · 80% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.4%, up from 4.39%. Voting rights 4.97%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260306718A1 by DSM IP Assets, B.V.: TISSUE REPAIR DEVICE AND MOLDING PROCESS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026209826A1 by DSM IP ASSETS B.V.: IMPROVED CBD FORMULATIONS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026209703A1 by DSM IP ASSETS B.V.: IMPROVED STARTER CULTURES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026209827A1 by DSM IP ASSETS B.V.: IMPROVED CANNABIDIOL FORMULATIONS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260305671A1 by DSM IP ASSETS B.V.: SOLID FORMULATIONS COMPRISING BETA-CAROTENE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260305633A1 by DSM IP ASSETS B.V.: NOVEL LACTOBACILLUS STRAINS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication AU2025281653A1 by DSM IP ASSETS B.V.: SUNSCREEN COMPOSITION COMPRISING RENEWABLE UV FILTERS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication EP4816345A1 by DSM IP Assets B.V.: METHOD FOR PRODUCING 2,3,5-TRIMETHYL BENZOQUINONE BY OXIDATION OF 2,3,6-TRIMETHYL PHENOL.
EPO patentsRelevance21
Watch · 80% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.58% of DSM-Firmenich AG (CH1216478797), down 0.08% from 0.66%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Millennium International Management LP net short position is 0.51% of DSM-Firmenich AG (CH1216478797). First position for this holder and ISIN in the AFM export.
AFM shortsRelevance68
Medium · 95% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260297119A1 by DSM IP ASSETS B.V.: IMPROVED ISOLATION OF STEVIOL GLYCOSIDES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026202193A1 by DSM IP ASSETS B.V.: SUSTAINED RELEASE OF BIOTHERAPEUTIC FROM BIODEGRADABLE POLYMER PARTICLES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication AU2025239778A1 by DSM IP ASSETS B.V.: COMBINATION OF MIXTURES OF HMOS WITH MFGM AND THEIR USE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260294812A1 by DSM IP Assets B.V.: CANNABIDIOL FORMULATIONS.
EPO patentsRelevance21
Watch · 80% confidence
- EuronextOther announcement
DSM FIRMENICH AG: dsm-firmenich completes €540 million share repurchase program. Topic: Change in Capital. Industry: 45102020 Food Products.
EuronextRelevance17
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026202192A1 by DSM IP ASSETS B.V.: SUSTAINED RELEASE OF BIOTHERAPEUTIC FROM BIODEGRADABLE POLYMER PARTICLES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication WO2026202194A1 by DSM IP ASSETS B.V.: SUSTAINED RELEASE OF BIOTHERAPEUTIC FROM BIODEGRADABLE POLYMER IMPLANTS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260294762A1 by DSM IP Assets B.V.: SKIN CARE COMPOSITION.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatentSubsidiary · DSM IP Assets, B.V.
Patent publication US20260297454A1 by DSM IP ASSETS B.V.: PROCESS FOR DEGUMMING FEEDSTOCK COMPRISING BRASSICA CARINATA OIL.
EPO patentsRelevance21
Watch · 80% confidence
- AFM insidersInsider transaction
Cotte-Tan S. (member Board of Directors) sold 336 gewoon aandeel at 98.19 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Pometta A. (member Board of Directors) bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Mahieu C. (member Board of Directors) sold 543 gewoon aandeel at 98.19 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Mann E. (member Board of Directors) sold 297 gewoon aandeel at 98.19 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Firmenich P. (member Board of Directors) bought 1,468 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,468 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Ridinger R. (member Board of Directors) sold 277 gewoon aandeel at 98.18 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Leysen T. (chairman Board of Directors) bought 4,791 gewoon aandeel at 98.02 EUR (CH1216478797); sold 4,791 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Ramsay J. (member Board of Directors) sold 277 gewoon aandeel at 98.19 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Paasschen, van F. (member Board of Directors) sold 277 gewoon aandeel at 98.19 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Wortmann - Kool C.M. (member Board of Directors) sold 494 gewoon aandeel at 98.19 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- AFM insidersInsider transaction
Firmenich A. (member Board of Directors) sold 354 gewoon aandeel at 98.19 EUR (CH1216478797); bought 1,198 gewoon aandeel at 98.02 EUR (CH1216478797); sold 1,198 restricted share right in DSM-Firmenich AG.
AFM insidersRelevance45
Medium · 94% confidence
- EuronextOther announcement
DSM FIRMENICH AG: Weekly progress on share repurchase program to cover share plans and reduce capital. Topic: Change in Capital. Industry: 45102020 Food Products.
EuronextRelevance17
Watch · 80% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.66% of DSM-Firmenich AG (CH1216478797), down 0.12% from 0.78%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.39%, up from 4.38%. Voting rights 4.97%, up from 4.96%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- EuronextOther announcement
DSM FIRMENICH AG: Weekly progress on share repurchase program to cover share plans and reduce capital. Topic: Change in Capital. Industry: 45102020 Food Products.
EuronextRelevance17
Watch · 80% confidence
- AFM stakesStake change
UBS Group AG capital interest in DSM-Firmenich AG is 7.27%, up from 5.47%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.38%, up from 4.03%. Voting rights 4.96%, up from 4.62%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.78% of DSM-Firmenich AG (CH1216478797), down 0.11% from 0.89%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.89% of DSM-Firmenich AG (CH1216478797), down 0.01% from 0.9%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Capital Fund Management S.A. net short position is 0.6% of DSM-Firmenich AG (CH1216478797), up 0.1% from 0.5%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
DSM-Firmenich AG capital interest in DSM-Firmenich AG is 3%, up from 0%. Voting rights 0%. Threshold crossed: 3%.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Capital Fund Management S.A. net short position is 0.5% of DSM-Firmenich AG (CH1216478797). First position for this holder and ISIN in the AFM export.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.9% of DSM-Firmenich AG (CH1216478797), up 0.02% from 0.88%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.88% of DSM-Firmenich AG (CH1216478797), down 0.11% from 0.99%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.03%, up from 4.01%. Voting rights 4.62%, up from 4.6%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4.01%, up from 4%. Voting rights 4.6%, up from 4.58%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.48% of DSM-Firmenich AG (CH1216478797), down 0.08% from 0.56%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.56% of DSM-Firmenich AG (CH1216478797), down 0.12% from 0.68%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.68% of DSM-Firmenich AG (CH1216478797), down 0.08% from 0.76%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Marshall Wace LLP net short position is 0.99% of DSM-Firmenich AG (CH1216478797), down 0.04% from 1.03%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.76% of DSM-Firmenich AG (CH1216478797), down 0.13% from 0.89%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Ilex Capital Partners (UK) LLP net short position is 2.1% of DSM-Firmenich AG (CH1216478797), up 0.09% from 2.01%.
AFM shortsRelevance68
High · 95% confidence
- AFM stakesStake change
BlackRock Inc. capital interest in DSM-Firmenich AG is 4%, down from 4.09%. Voting rights 4.58%, down from 4.67%. No AFM threshold crossed.
AFM stakesRelevance87
Medium · 93% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.89% of DSM-Firmenich AG (CH1216478797), down 0.01% from 0.9%.
AFM shortsRelevance68
Medium · 95% confidence
- AFM shortsNet short position
Citadel Advisors LLC net short position is 0.9% of DSM-Firmenich AG (CH1216478797), up 0.1% from 0.8%.
AFM shortsRelevance68
Medium · 95% confidence
- EC mergersEC merger decision
EC merger decision M.12382 CVC / DSM ANIMAL NUTRITION AND HEALTH BUSINESS. Phase I, cleared.
EC mergersRelevance106
Medium · 86% confidence
- EC mergersEC merger notification
EC merger notification M.12382 CVC / DSM ANIMAL NUTRITION AND HEALTH BUSINESS. Simplified procedure.
EC mergersRelevance101
Medium · 86% confidence